Financing equitable access to antiretroviral treatment in South Africa
<p>Abstract</p> <p>Background</p> <p>While South Africa spends approximately 7.4% of GDP on healthcare, only 43% of these funds are spent in the public system, which is tasked with the provision of care to the majority of the population including a large proportion of t...
Main Authors: | McIntyre Di, Cleary Susan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | BMC Health Services Research |
Online Access: | http://www.biomedcentral.com/1472-6963/10/S1/S2 |
Similar Items
-
The cost-effectiveness of Antiretroviral Treatment in Khayelitsha, South Africa – a primary data analysis
by: Boulle Andrew M, et al.
Published: (2006-12-01) -
Access to antiretroviral treatment in South Africa, 2004 - 2011
by: Leigh Francis Johnson
Published: (2012-03-01) -
Universal health coverage financing in South Africa: wishes vs reality
by: Janet Michel, et al.
Published: (2020-07-01) -
Equitable access to digital higher education for students with disabilities in South Africa
by: Johannes N. Zongozzi, et al.
Published: (2025-02-01) -
Designing an Equitable Strategy for Allocating Antiretroviral Treatments
Published: (2005-01-01)